D1 Capital
DHR · Medicine & biotech

Danaher

Makes lab tools and tests used by scientists and drug makers.
No change
D1 Capital owns 2.3 million shares of Danaher, worth about $435 million. That’s $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
2,304,148
Jun 30
2,282,039

The numbers

Shares they own
2,282,039
Change since Mar 31
−22,109
tiny change (1.0%)
Shares on Mar 31
2,304,148
Value on Jun 30, 2026
$434,682,789
about $435 million
Share of their money
1.2%
$1 of every $100 · 8th of 54
Price per share on Jun 30
$190.48
Kind
Shares
More about Danaher
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works